Correlation Between Tela Bio and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tela Bio and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tela Bio and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tela Bio and Neuropace, you can compare the effects of market volatilities on Tela Bio and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tela Bio with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tela Bio and Neuropace.

Diversification Opportunities for Tela Bio and Neuropace

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Tela and Neuropace is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Tela Bio and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Tela Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tela Bio are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Tela Bio i.e., Tela Bio and Neuropace go up and down completely randomly.

Pair Corralation between Tela Bio and Neuropace

Given the investment horizon of 90 days Tela Bio is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Tela Bio is 1.69 times less risky than Neuropace. The stock trades about -0.04 of its potential returns per unit of risk. The Neuropace is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  158.00  in Neuropace on August 24, 2024 and sell it today you would earn a total of  742.00  from holding Neuropace or generate 469.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tela Bio  vs.  Neuropace

 Performance 
       Timeline  
Tela Bio 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Tela Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong essential indicators, Tela Bio is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Neuropace 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Tela Bio and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tela Bio and Neuropace

The main advantage of trading using opposite Tela Bio and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tela Bio position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Tela Bio and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Correlations
Find global opportunities by holding instruments from different markets